Release Date: 13/03/09 17:29 Summary: Appendix 3B Price Sensitive: No Download Document 70.15KB Download
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market